CONDUIT PHARMACEUTICALS INC.·4

Dec 5, 5:20 PM ET

Sragovicz Adam 4

4 · CONDUIT PHARMACEUTICALS INC. · Filed Dec 5, 2023

Insider Transaction Report

Form 4
Period: 2023-12-01
Sragovicz Adam
DirectorCFO and Treasurer
Transactions
  • Award

    Restricted Stock Units

    2023-12-01+74,54574,545 total
Footnotes (1)
  • [F1]The restricted stock units were granted with a vesting schedule of 33.3% on each of the first three anniversaries of the vesting commencement date, which is September 22, 2023.

Documents

1 file
  • 4
    ownership.xmlPrimary